Assessing the safety of gene therapy vectors expressing an enhanced gamma-globin gene for the cure of sickle cell anemia
Saved in:
| Main Author: | Stefano Rivella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050125000762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models
by: Archana Shrestha, et al.
Published: (2025-06-01) -
Fine tuning of globin gene expression by DNA methylation.
by: Alon Goren, et al.
Published: (2006-12-01) -
Gamma Globin Gene “Switch On” by Dietary Source of Short Chain Fatty Acids as a Therapy for the Management of Sickle Cell Anaemia in Patients Attending Federal Medical Centre Gusau, Zamfara State
by: Matazu, I. K., et al.
Published: (2016-12-01) -
GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES
by: Laura Breda, et al.
Published: (2009-11-01) -
THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024-02-01)